HOLX241220P65000
- 0.03
- -0.03-50.00%
Hologic Newsroom
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Hologic Analyst Ratings
UBS Downgrades Hologic(HOLX.US) to Hold Rating, Cuts Target Price to $84
Hologic Analyst Ratings
Wolfe Research Initiates Hologic(HOLX.US) With Hold Rating
Stephens Maintains Hologic(HOLX.US) With Buy Rating, Raises Target Price to $90
Morgan Stanley Maintains Hologic(HOLX.US) With Hold Rating, Maintains Target Price $84
Nephron Initiates Hologic(HOLX.US) With Hold Rating, Announces Target Price $80
A Quick Look at Today's Ratings for Hologic(HOLX.US), With a Forecast Between $84 to $90
RBC Capital Reaffirms Their Hold Rating on Hologic (HOLX)
Stability in Guidelines and Modest Growth Prospects Justify Hold Rating for Hologic
Buy Rating for Hologic Amid Manageable Transition to HPV Testing
BNP Paribas Exane Trims Hologic Price Target to $95 From $96, Maintains Outperform Rating
Jefferies Initiates Coverage On Hologic With Hold Rating, Announces Price Target of $85
Hologic Analyst Ratings
Jefferies Downgrades Hologic(HOLX.US) to Hold Rating, Cuts Target Price to $85
Morgan Stanley Maintains Hologic(HOLX.US) With Hold Rating, Maintains Target Price $84
A Quick Look at Today's Ratings for Hologic(HOLX.US), With a Forecast Between $84 to $95
Hologic's Strategic Advancements and Robust Market Position Earns 'Buy' Rating Despite Conservative Outlook